ソース:[1] Recursion Pharmaceuticals, Inc. (RXRX) Secures $12.5M Milestone From Rallybio as REV102 Advances (https://finance.yahoo.com/news/recursion-phar ...)[2] Recursion Pharmaceuticals Acquires Full Interest in ENPP1 Inhibitor Program from Rallybio | RXRX stock news - GuruFocus (https://vertexaisearch.cloud.google.com/groun ...)[3] RXRX Stock Surges: What's Next? (https://vertexaisearch.cloud.google.com/groun ...)